Genética y Clínica de las Neoplasias Hematológicas y el Trasplante Hematopoyético

Galán-Gómez, V; González-Martínez, B; Alonso-Saladrigues, A; Rives, S; Herrero, B; Kwon, M; Sánchez-Pina, J; Minguillón, J; Martínez-Romera, I; Aguilar, IM; Mestre-Durán, C; Casado, G; Sánchez-Martín, M; Echecopar, C; González-Pérez, C; León-Triana, O; Aguirre-Portolés, C; Molinos-Quintana, A; Barba, P; Balsalobre, P; Pérez-Martínez, A.

Siltuximab for the treatment of early complications after chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia in children, adolescents, and young adults

EXPERIMENTAL HEMATOLOGY & ONCOLOGY. 2025; 14(1): Nº de citas: 2 [doi:10.1186/s40164-025-00638-3]

Tedeschi, A; Auer, R; Autore, F; Castillo, JJ; Gatt, ME; Kimby, E; Moreno, DF; Owen, RG; Qiu, LG; Roccaro, AM; Sarosiek, S; Sekiguchi, N; Seymour, JF; Varettoni, M; Patterson, CJ; Matous, JV; Buske, C; Treon, SP; Sanz, RG.

Report of Consensus Panel 4 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with non-IgM lymphoplasmacytic lymphoma

SEMINARS IN HEMATOLOGY. 2025; 62(2): 106-112 Nº de citas: 1 [doi:10.1053/j.seminhematol.2025.04.002]

Gómez-Seguí, I; Cid, J; Lozano, M; Mingot-Castellano, ME; Pascual-Izquierdo, C; del Castillo, LMG; Estevez, JMV; Garcia-Candel, F; Balarezo, MJ; Valcarcel, D; Perez-Avila, CC; Ramirez, MA; Lakhwani, S; Jimenez, MGM; Hernandez, AYO; Gala, JMG; Nieto, JM; Goterris, R; Docampo, MF; Pell-Ilderton, CS; de la Rubia, J.

Caplacizumab treatment in elderly patients with iTTP: Experience from the Spanish TTP Registry

Hemasphere. 2025; 9(4): Nº de citas: 1 [doi:10.1002/hem3.70109]

Stock, CNT; Chillón, CJ; Hernández, CL; Moro, FM; Palomanes, JM; Villaespesa, MP; de Abia, AL; Santiago, ER; Martín, ER; Rodríguez, AC; Gutiérrez, VG; Jiménez, GM; Jiménez, JL; Puente, PH.

Combination of disease burden before allogeneic transplantation and early post-transplant minimal residual disease predicts survival in patients with acute myeloid leukemia

ANNALS OF HEMATOLOGY. 2025; 104(4): 2469-2481 [doi:10.1007/s00277-025-06325-x]

Iacoboni, G; Rejeski, K; Navarro, V; van Meerten, T; Rampotas, A; Martin-López, AA; Bastos, M; Benzaquén, A; Reguera-Ortega, JL; Carpio, C; Roddie, C; López-Corral, L; Delgado-Serrano, J; Landwehr, M; Stock, S; de Tena, PS; Abrisqueta, P; de Boer, J; Garcia-Sancho, AM; Hernani, R; Kwon, M; Subklewe, M; O'Reilly, M; Barba, P.

Site-specific analysis of extranodal involvement in large B-cell lymphoma reveals distinct efficacy with chimeric antigen receptor T-cell therapy

LEUKEMIA. 2025; 39(5): 1196-1205 Nº de citas: 1 [doi:10.1038/s41375-025-02582-x]

Coppo, P; Bubenheim, M; Benhamou, Y; Voelker, L; Brinkkoetter, P; Kuehne, L; Knoebl, P; Mingot-Castellano, ME; Pascual-Izquierdo, C; de la Rubia, J; Garma, JD; Chaturvedi, S; Masias, C; Mazepa, M; Zheng, XL; Sinkovits, G; Reti, M; Patriquin, CJ; Pavenski, K; Boechat, T; Farias, J; Ribeiro, EFO; Andrade, MLLD; Veyradier, A; Joly, B; Bouzid, R; Sakai, K; Matsumoto, M; Agosti, P; Mancini, I; Peyvandi, F; Gavriilaki, E; Stubbs, M; Hmaid, A; Cataland, S; Laemmle, B; Scully, M.

Caplacizumab use in immune-mediated thrombotic thrombocytopenic purpura: an international multicentre retrospective Cohort study (The Capla 1000+project)

Eclinicalmedicine. 2025; 82: Nº de citas: 2 [doi:10.1016/j.eclinm.2025.103168]

Sureda, A; García-Sanz, R; Domingo-Domenech, E; Capote, FJ; Gutiérrez, A; Rodriguez, A; Aguiar, D; Giraldo, P; Infante, MS; López-Jiménez, J; Martínez, C; Sánchez-González, B; Ortiz-Romero, PL; Grande, M; Baeza-Montañez, L.

Retreatment with Brentuximab Vedotin in Patients with Relapsed/Refractory CD30+Malignancies: A Retrospective Medical Chart Review Study in Spain-The BELIEVE Study

Cancers. 2025; 17(7): [doi:10.3390/cancers17071137]

Poza, M; Martin-Muñoz, A; López-Pereira, P; Figaredo, G; Zamanillo, I; Iñiguez, R; Oliveira, AC; Baumann, T; Rodríguez-Izquierdo, A; Grande, C; Sarandeses, P; Revilla, E; Cortés, M; Ayala, R; Calbacho, M; Martínez, J; Barrio, S; Jiménez-Ubieto, A.

Exploratory Study to Evaluate the Impact of Interim PET/CT Assessment in First-Line Follicular Lymphoma

Cancers. 2025; 17(7): [doi:10.3390/cancers17071065]

Pena-Burgos, EM; del Carpio, GS; Tapia-Viñe, M; Suárez-González, J; Buño, I; Ortiz-Cruz, E; Pozo-Kreilinger, JJ.

Liposclerosing Myxofibrous Tumor: A Separated Clinical Entity?

Diagnostics. 2025; 15(5): [doi:10.3390/diagnostics15050536]

Camacho-Arteaga, L; Iacoboni, G; Kwon, M; Bailén, R; Hernani, R; Benzaquén, A; López-Corral, L; Pérez-López, E; Leguízamo-Martínez, LM; Calvo-Orteu, M; Guerreiro, M; Balaguer-Rosello, A; Alonso-Martínez, C; Vidal, X; Barba, P; Agustí, A.

Late Adverse Events After Chimeric Antigen Receptor T-Cell Therapy for Patients With Aggressive B-Cell Non-Hodgkin Lymphoma

JAMA Network Open. 2025; 8(2): [doi:10.1001/jamanetworkopen.2024.61683]

Sanz, J; Labopin, M; Versluis, J; Blaise, D; Lazzari, L; Montoro, J; Van Gorkom, G; von dem Borne, P; Sandrine, L; Rovira, M; Remenyi, P; Chevallier, P; Kwon, M; Eder, M; Vydra, J; Brissot, E; Spyridonidis, A; Piemontese, S; Mohty, M; Ciceri, F.

Cytogenetic and molecular risk-driven conditioning intensity in acute myeloid leukemia patients undergoing stem cell transplantation with post-transplant cyclophosphamide: a study from the acute leukemia working party of the EBMT

BONE MARROW TRANSPLANTATION. 2025; 60(4): 529-534 Nº de citas: 1 [doi:10.1038/s41409-025-02527-z]

Spyridonidis, A; Labopin, M; Savani, BP; Kulagin, A; Blaise, D; Broers, AEC; Sica, S; Raiola, AM; Vydra, J; Choi, G; Rovira, M; Kwon, M; Sanz, J; Itäla-Remes, M; von dem Borne, P; Esquirol, A; Koc, Y; Brissot, E; Nagler, A; Mohty, M; Ciceri, F.

The impact of individual comorbidities in transplant recipients receiving post-transplant cyclophosphamide

BONE MARROW TRANSPLANTATION. 2025; 60(4): 499-506 [doi:10.1038/s41409-025-02514-4]

Ramírez, MJ; Pujol, R; Minguillón, J; Bogliolo, M; Persico, I; Cavero, D; de la Cal, A; Río, P; Navarro, S; Casado, JA; Bailador, A; de la Fuente, AS; de Heredia, ML; Almazán, F; Antelo, ML; Argilés, B; Badell, I; Baragaño, M; Beléndez, C; Bermúdez, M; Bernués, M; Buedo, MI; Carrasco, E; Català, A; Costa, D; Cuesta, I; Fernández-Delgado, R; Fernández-Teijeir, A; Figuera, A; García, M; Gondra, A; González, M; Muñiz, SG; Hernández-Rodríguez, I; Ibañez, F; Kelleher, NJ; Lendínez, F; López, M; López-Almaraz, R; Marchante, I; Mendoza, C; Nieto, J; Ojeda, E; Payán-Pernía, S; Peláez, I; de Soto, IP; Portugal, R; Ramos-Arroyo, MA; Regueiro, A; Rodríguez, A; Rosell, J; Saez, R; Sánchez, J; Sánchez, M; Senent, ML; Tapia, M; Trujillo-Quintero, JP; Vagace, JM; Verdú-Amorós, J; Verdugo, V; Vidales, I; Villarreal, J; Díaz-de-Heredia, C; Sevilla, J; Bueren, J; Surralles, J.

Prognostic significance of mutation type and chromosome fragility in Fanconi anemia

AMERICAN JOURNAL OF HEMATOLOGY. 2025; 100(2): 272-284 Nº de citas: 4 [doi:10.1002/ajh.27520]

Veintimilla, C; Miyares, AAU; Buenestado-Serrano, S; Palomino-Cabrera, R; Centurion, IG; Catalán, P; Muñoz, P; Pérez-Lago, L; de Viedma, DG.

Occult COVID-19 in an immunosuppressed patient with migratory pulmonary infiltrates

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2025; 151: [doi:10.1016/j.ijid.2024.107296]

Lasa, M; Notarfranchi, L; Agullo, C; Gonzalez, C; Castro, S; Perez, JJ; Burgos, L; Guerrero, C; Calasanz, MJ; Flores-Montero, J; Oriol, A; Bargay, J; Rios, R; Cabanas, V; Cabrera, C; Martinez-Martinez, R; Encinas, C; De Arriba, F; Hernandez, MT; Palomera, L; Orfao, A; Martinez-Lopez, J; Mateos, MV; San-Miguel, J; Lahuerta, JJ; Rosiñol, L; Blade, J; Cedena, MT; Puig, N; Paiva, B.

Minimally Invasive Assessment of Peripheral Residual Disease During Maintenance or Observation in Transplant-Eligible Patients With Multiple Myeloma

JOURNAL OF CLINICAL ONCOLOGY. 2025; 43(2): Nº de citas: 3 [doi:10.1200/JCO.24.00635]

Pascual-Izquierdo, C; Llacer-Ferrandis, MJ; de-la-Iglesia, A; Monsalvo-Saornil, S; Menor-Gómez, M; Gil-Fernández, JJ; Chica-Gullon, E; alvarez-Roman, MT; Perez-Segura, G; Zafra, D; Ortuzar-Pasalodos, A; González-Gascón-y-Marín, IT; Moreno, G; Arquero-Portero, T; Moreno-Carbonell, M; Revilla, N.

Avatrombopag in adults with immune thrombocytopenia: A multicentre real-life observational study in Madrid, Spain (AVAMAD study)

BRITISH JOURNAL OF HAEMATOLOGY. 2025; 206(2): 652-656 Nº de citas: 1 [doi:10.1111/bjh.19975]

de Larrea, CF; Loscertales, J; Cabañas, V; Freiria, C; Blanchard, MJ; Askari, E; Perez, ML; Abril, L; Pardo, JL; Pinzón, S; Gálvez, JD; Amer, N; Páyer, AR; Sánchez, RG; Alcalá, MM; Capote, FJ; Moreno, D; Bolumburu, C; Rubio-Azpeitia, E; Sanz, RG.

Observational retrospective study of the treatment of Waldenström's macroglobulinemia with ibrutinib in routine clinical practice in Spain

Therapeutic Advances in Hematology. 2025; 16: [doi:10.1177/20406207251379670]

Kwon, M.

Real-world use of isavuconazole in adult oncohematology patients

REVISTA IBEROAMERICANA DE MICOLOGIA. 2025; 42(1): 22-25 [doi:10.1016/j.riam.2025.02.001]